Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Trend
Above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↑ 100% above average
Average (39q)
-1.36%
Historical baseline
Range
High:116.56%
Low:-100.00%
Volatility
-15963.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q2 2023 | 1.20% |
| Q1 2023 | -2.20% |
| Q4 2022 | -0.15% |
| Q3 2022 | 1.19% |
| Q2 2022 | 1.20% |
| Q1 2022 | -1.19% |
| Q4 2021 | -1.32% |
| Q3 2021 | 0.29% |
| Q2 2021 | 2.41% |
| Q1 2021 | -1.34% |
| Q4 2020 | -1.03% |
| Q3 2020 | 0.00% |
| Q2 2020 | 1.04% |
| Q1 2020 | 0.00% |
| Q4 2019 | -1.03% |
| Q3 2019 | -0.15% |
| Q2 2019 | 2.40% |
| Q1 2019 | -1.19% |
| Q4 2018 | 9.24% |
| Q3 2018 | 0.00% |
| Q2 2018 | 2.15% |
| Q1 2018 | -1.15% |
| Q4 2017 | -1.13% |
| Q3 2017 | 0.16% |
| Q2 2017 | 0.98% |
| Q1 2017 | 0.16% |
| Q4 2016 | 72.80% |
| Q3 2016 | 116.56% |
| Q2 2016 | 30.40% |
| Q1 2016 | -84.61% |
| Q4 2015 | 0.00% |